SwRI develops a unique technology to screen new DNA-targeting therapeutics

Post author:
Post published:August 19, 2024
Post category:uncategorized

Southwest Research Institute (SwRI) has developed a unique technology to screen new DNA-targeting therapeutics designed to treat cancer and other diseases.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Scoping review identifies major social determinants of health that hinder breast cancer screening

Study finds microplastics in semen and urine, linking PTFE exposure to lower sperm count

Pediatric viral threats surge in the 21st century: A call for One Health approach

Helpful Links

Subscribe To Us